Clinical Trial Update: Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated pharmacokinetics and optimal dosing of a once-daily aminoglycoside in burn patients to guide dosing strategies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Infection

Drugs mentioned

• Unspecified aminoglycoside (aminoglycoside)

Snippet

Sponsor: Sandra Walker | Conditions: Burns, Infection | Phase 1, Phase 2 | Status: COMPLETED